Q4 2025 Management View CEO Sheri Dodd highlighted 2025 as a pivotal year, stating that "Through disciplined execution across our commercial and operational strategies, we delivered strong profitable revenue growth while continuing to make critical investments in people and

Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that it has acquired LymphaTech Inc.

The Internet in recent years has not just seen an incremental upgrade from 2G to 3G or 4G but a significant leap forward with the evolution of the fifth-generation network, 5G. Many new advancing technologies and disruptive innovations have already ushered ...

Full-year 2025 revenue guidance was revised to $309 million to $315 million, reflecting 5% to 8% growth year-over-year. Airway clearance revenue is expected to grow by 20% to 23% for the year, driven by strong AffloVest performance and strategic DME ...